BeStock  
Stocks › Biotechnology › AVLN

Avalyn Pharma AVLN

US equityMarket cap rank #3002Biotechnology
$28.40 −$0.30 (-1.05%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $28.40 0.00%
Open$28.06
Prev close$28.70
Day range$27.85 – $29.38
Volume214.3K
Market cap$1.26B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-12.3x
CheapRich

Above its usual level · 74th percentile, 5-year average -13.1x

Price / book3.6x
CheapRich

Near the top of its 5-year range · 81st percentile, 5-year average -0.9x

#4016 of 5329 stocks by PB (1 = cheapest)

P/E over five years

-18x-12x-5x1xApr '26Aug '26Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$32.76
Price vs. fair value-13.3%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.64 – -0.87 81% (pricier than usual) #4016 of 5329 (1 = cheapest)
PE -12.29 -9.98 -13.11 74% (pricier than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on AVLN.

Sign in to join the discussion.

Scroll to Top